Amlodipine benazepril combination therapy
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Amlodipine/Benazepril Combination Therapy for Hypertension
Amlodipine/benazepril, a fixed-dose combination of a calcium channel blocker and an ACE inhibitor, has been shown to provide significant blood pressure (BP) reduction in patients with hypertension, especially those not adequately controlled on monotherapy. Studies consistently report that this combination achieves greater BP lowering compared to either drug alone, with higher rates of patients reaching BP targets and improved 24-hour BP control 1234+3 MORE. In both mild-to-moderate and severe hypertension, combination therapy outperforms monotherapy in both clinical trial and real-world practice settings 457.
Safety and Tolerability of Amlodipine/Benazepril Fixed-Dose Combination
The combination of amlodipine and benazepril is generally well tolerated. The incidence of adverse effects is similar to or lower than that seen with monotherapy, and the rate of drug discontinuation due to side effects is among the lowest compared to other antihypertensive regimens 1368. Notably, the combination reduces the risk of peripheral edema, a common side effect of amlodipine, and maintains a favorable safety profile even in older adults and those with multiple comorbidities . In long-term care settings, switching to fixed-dose amlodipine/benazepril reduced both adverse events and drug costs while maintaining BP control .
Cardiovascular Outcomes and Comparative Effectiveness
Large-scale studies have demonstrated that amlodipine/benazepril not only lowers BP effectively but also reduces the risk of major cardiovascular events. In high-risk hypertensive patients, this combination was superior to benazepril plus hydrochlorothiazide in reducing the incidence of cardiovascular events, including heart attack and stroke . Other research shows that amlodipine/benazepril is at least as effective as other common dual therapies, with some evidence suggesting a lower incidence of dry cough compared to combinations containing thiazide diuretics 910.
Patient Adherence and Cost Considerations
Fixed-dose combination therapy improves medication adherence due to the convenience of a single pill, which can lead to better long-term BP control 16. Additionally, the cost of the combination product is often lower than the sum of its individual components, making it a cost-effective option for many patients 16.
Conclusion
Amlodipine/benazepril combination therapy is a highly effective and well-tolerated option for patients with hypertension, particularly those who do not achieve adequate control with monotherapy. It offers superior BP reduction, improved cardiovascular outcomes, fewer side effects, better adherence, and cost savings compared to many other antihypertensive regimens. This makes it a strong choice for both initial combination therapy and for patients requiring escalation from single-agent treatment 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic